Stephen Taub Premium Hedge Funds Are Holding Their Breath on This Biopharma IPO Several prominent hedge funds disclosed sizable stakes in PepGen, which went public earlier this month. Stephen Taub May 23, 2022 Carsten Snejbjerg/Bloomberg